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Severe parenchymatous diseases
of the liver, both acute and chronic,
are frequently associated with hepatic encephalopathy. This term is
preferable to that of hepatic coma,
as it encompasses the whole spectrum of changes from bizarre alterations of behavior to various
degrees of disturbance of consciousness, as well as protean neurologic
manifestations. In many instances
it is a reversible phenomenon, occurring either spontaneously or as
the result of various therapeutic
agents. The puzzling feature of
hepatic encephalopathy is the discrepancy between dramatic clinical
features and paucity of histopathological changes in the brain. The
only histological changes encountered with regularity in patients
with this entity are diffusely swollen and enlarged astrocytes (Adams and Foley, 1953). With no macroscopic or microscopic changes to
account for cerebral dysfunction,
it is likely that hepatic encephalopathy is caused by profound, yet
undefined metabolic abnormalities.
A relationship between ammonia
toxicity and cerebral dysfunction
has been suspected since the discovery of "meat intoxication" in
Eck fistula dogs. The clinical relationship between liver disease, cerebral dysfunction and disordered
ammonia metabolism was established by Gabuzda, Phillips, and
Davidson (1952) and confirmed
by others.

* Presented at the Thirty-Ninth
Annual McGuire Lecture Series, November 9-10, 1967, Medical College
of Virginia, Richmond.

Sources of Ammonia

The major sources of ammonia
in humans are the bowel and the
kidney. Ammonia is produced in
the bowel by the action of bacterial and digestive enzymes on
protein and urea, the major contributor probably being the right
colon ( Gryska and Barsamian,
1958; Silen et al., 1955; Webster,
Davidson, and Gabuzda, 1958). In
patients with cirrhosis, the upper
small bowel, normally sterile, is
contaminated by bacteria, thus
contributing significantly to ammonia production (Martini et al.,
1957). The reason for abnormal
bacterial growth in the upper small
bowel in patients with cirrhosis is
not known.
Hydrolysis of the urea is an additional source of ammonia. About
25 % of the endogenous urea is
not excreted by the kidney but is
hydrolyzed in the gastrointestinal
tract at a constant rate of 0.3 mg
per hour to a total of 7.2 gm of
urea daily. This is equivalent in
nitrogen content to 11 gm of
NH 4 Cl or 18 gm of protein (Walser and Bodenlos, 1959). As patients with advanced cirrhosis in
terminal stages frequently develop
azotemia secondary to renal failure, it is easy to visualize how
hydrolysis of this excess urea in
the gut could precipitate hepatic
coma. All these factors, when coupled with a larger protein load,
either secondary to bleeding or
high protein diet, can contribute
significantly to the occurrence of
hepatic encephalopathy.
The second major source of ammonia is the kidney. Ammonia is
produced in the kidney by deamiMCV QUARTERLY 4(1): 32-37, 1968
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nation of glutamine and other
amino acids, resulting in higher
renal vein ammonia. The difference between renal vein and arterial ammonia is even more pronounced in patients with cirrhosis,
particularly if they are potassium
deficient, on diuretic therapy, or
both (Weil-Malherbe, 1950; Owen
et al., 1960). The mechanism for
preferential secretion of ammonia
into the renal vein is not known.
With acetazolamide therapy, increase in renal vein ammonia was
coupled with equivalent fall in
urinary ammonia and a rise in
urine pH. The latter may explain
the shift in partition of ammonia
between urine and renal vein.
The role of hypokalemia in an
increased renal production of ammonia is not understood, but it
can be prevented by correction of
potassium deficit. In patients with
liver disease who are frequently
rendered hypokalemic with injudicious use of diuretics, this mechanism may be responsible for the
precipitation of hepatic encephalopathy.
Removal Mechanisms and
Distribution of Ammonia

Ammonia is detoxified in the
liver by forming urea through the
Krebs-Henseleit cycle. As a result
of the marked collateral circulation and hepatocellular disease,
the removal of am monia by the
liver in patients with cirrhosis is
diminished. Very rarely in cases
of massive fulminating liver failure, the urea cycle does not function at all, resulting in decreased
blood urea nitrogen levels.
The removal of ammonia from
the blood and tissues can also be
accomplished through the reaction
in which a-ketoglutarate combines
with ammonia to form glutamic
acid (Weil-Malherbe, 1950).
Through the process of transamination, .a-ketoglutarate can again become available either to combine
with more ammonia or to continue
in the tricarboxylic acid cycle (Fig.
1). Furthermore, glutarnic acid

can react with ammonia to form
glutamine in the reaction requiring ATP.
These reactions, thus, probably
serve as a defense against accumulation of ammonia, and at the
same time offer a reasonable explanation for frequent elevation
of glutamic acid and glutamine in
patients with chronic liver disease.
Exhalation of ammonia via the
lungs is a minor mechanism of
ammonia removal.
As a consequence of hepatic
parenchymal disease and portalsystemic shunts, the nitrogenous
compounds from the portal blood
bypass the liver and reach systemic circulation, resulting in the
elevation of blood ammonia. Blood
ammonia, however, is not a good
index of "ammonia toxicity" for
several reasons. First, blood ammonia correlates poorly with the
state of consciousness (Moore,
Strohmeyer, and Chalmers, 1963).
Secondly, in the congenital defects
of urea biosynthesis, blood ammonia levels may be much higher
than those found in patients with
hepatic coma with no neuropsychiatric manifestations (Russell et
al., 1962) . Finally, the experiments by Warren et al. ( 1960;
Warren, 1958; Stabenau, Warren
and Rall, 1959) have shown that
another variable, pH, might play
an important role in the pathogenesis of hepatic coma. They observed that the differential toxicity
of various ammonium salts de-
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pended upon the change in the pH
of the blood induced by a given
salt.
Ammonia, in the blood or any
biological fluid, exists in two forms :
ammonium ion (NH4 +) and free
ammonia (NH3°) . According to
the Henderson-Hasselbalch equationNH3°
pH = pK" +log NH. +
the relative proportion of each
component is directly dependent
upon pH. Knowing the pK,. of
ammonia (about 9 .15) , total blood
ammonia (obtained by any standard microdiffusion test) and pH,
one can calculate the relative proportion of ionized (NH4 +) and
un-ionized free ammonia (NH 3°) .
The relative proportions of un-ionized ammonia at pH's of 6, 7, 8,
and 9.15 are approximately 0.1 %,
1 %, 10 % , and 50 % . According to
present concepts, only un-ionized
free ammonia is capable of crossing
the cell membrane. At the normal
blood pH only a small proportion
of ammonia is in this form. The
change of pH to the alkaline side
will increase the proportion of unionized ammonia (NH3 ) and, thus,
theoretically, increase the chance of
inducing hepatic encephalopathy.
According to the pH gradient
distribution hypothesis, distribution
of ammonia from blood to tissue
seems to be dependent upon a pH
difference between the two compartments. If a membrane, such as

KETOGLUTARIC A C I D x N H 3 + DPNH + H +
DEHYDROGENASE
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H20 + DPN +

L _ ASPARTIC ACID x c L - KETOGLUTARJC A C I D x NH3 + DPNH + H +
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Fig. I-Ammonia detoxication reaction involving a-ketoglutaric Acid. The
transamination reactions involving glutamic acid are also presented.
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the blood-cerebrospinal fluid barrier, is permeable only to un-ionized
ammonia, the concentration gradient which normally exists between
·extra- and intracellular fluid should
be maintained, depending upon the
pH in each compartment. With the
change of this gradient, the redistribution of un-ionized ammonia
·occurs, providing the change takes
place on one side of the membrane
·only or both sides in the opposite
direction. Consequently, an in·crease in extracellular pH, such as
in metabolic alkalosis, will both
increase the relative proportion of
un-ionized ammonia and facilitate
its transfer across the membrane,
resulting in a rise of intracellular
:ammonia.
Respiratory and metabolic alkalosis are frequently encountered in
patients with cirrhosis. Respiratory
alkalosis with hyperventilation is
the most frequent acid-base disturbance in these patients. The
underlying mechanism for its oc·Currence is not clear. This type of
alkalosis, however, does not cause
·significant change in the pH gra·dient, as carbon dioxide diffuses
freely across the cell membranes
and, consequently, no change in
a mmonia distribution occurs. Conversely, in patients with metabolic
.alkalosis, the pH gradient will be
increased, as the pH change will
·Occur on one side of the membrane
·only, thus resulting in redistribu-

tion of ammonia. Hypokalemic,
hypochloremic alkalosis accompanied by intracellular acidosis
frequently occurs in patients with
cirrhosis who are treated with potent diuretics. As a result of metabolic alkalosis, formation of un-ionized ammonia (NH3°) is favored,
and its transport across the membrane is facilitated. This mechanism may be partially responsible
for the frequent precipitation of
hepatic encephalopathy in cirrhotics on this therapy.
Whether aforementioned theoretical considerations play an important role in the pathogenesis of
hepatic coma is not as yet entirely
clear, largely because no direct
method for measuring un-ionized
ammonia (NH3 °) is available.
Clinical trial with the intention
of implementing these theoretical
considerations in patients with hepatic coma was not successful
(Warren et al., 1960) . The administration of O.lN HCL intravenously for a brief period of time,
in an attempt to lower the pH, did
not lead to any improvement in
the state of consciousness. The
duration of this clinical trial was
very short and, therefore, inadequate to fully test this hypothesis.
Pathogenetic Mechanisms

Hepatic encephalopathy can be
classified either as spontaneous

TABLE 1
Precipitating Factors
Gastrointestinal Bleeding
Excessive Amounts of Nitrogenous Substances (Dietary Protein, Ammonium
Salts, Urea, Amino Acids)
Azotemia
Diuretics
Metabolic Alkalosis With or Without Hypokalemia
Acute Infections
Sedatives, Hypnotics, Analgesics (Chloral Hydrate, Paraldehyde, Barbiturates,
Opiates)
Major Surgical Procedures
Massive Paracentesis
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(endogenous) or induced (exogenous). As far as the pathogenesis is concerned, this classification is somewhat arbitrary. It
only implies that exogenous coma
is precipitated by a variety of factors (Table 1) and, consequently,
does not necessarily imply extremely poor liver function. Conversely, spontaneous or endogenous coma usually implies active,
sometimes fulminating liver disease, occurring without presence
of precipitating factors and, consequently, carries a worse prognosis.
The pathogenetic mechanisms
involved in hepatic encephalopathy
are not known. It is generally accepted, but not proven, that either
ammonia or a nitrogenous substance liberating ammonia is in
some way associated with the syndrome of hepatic encephalopathy.
In addition to, or because of disordered ammonia metaholism, patients with hepatic encephalopathy
have a markedly altered metabolism of glucose and oxygen. This
is manifested by the accumulation
of various intermediates of tricarboxylic acid (TCA) cycle, pyruvic
and lactic acid in the blood and
in the spinal fluid. Furthermore,
brain oxygen uptake and cerebral
blood flow in these patients are decreased between 25 % and 50%.
All of these facts indicate that
profound metabolic biochemical
changes take place in these patients,
some of them affecting cerebral
energy metabolism. Such disturbance of cerebral energy metabolism
is now thought to be the basis of
neurological changes in ammonia
intoxication. Neurologic findings of
hepatic encephalopathy such as
asterixis, decerebrate rigidity, hyperpnea and coma suggest malfunction of the specific structures in the
base of the brain and possibly their
cortical connections (Magoun ,
1963; Plum and Posner, 1966).
The understanding of biochemical disorders involved in hepatic
coma was hampered by the impossibility of studying coma in humans. Most of the available data
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an important intermediate of the
TCA cycle. They suggested that,
when an excess of ammonia is presented to the brain, depletion of
a-ketoglutarate takes place through
its reaction with ammonia to form
glutamic acid. This reaction (Fig.
2) is catalyzed by glutamic dehydrogenase and uses DPNH, as an
electron donor. Diversion of aketoglutarate from the TCA cycle
diminishes the rate of formation of

are from in vitro experiments or
animal models. Thus, it must be
stressed with great emphasis that
extrapolation of these experiments
to human situations should be done
with reservation and due caution.
Hessman and Hessman (1955)
proposed a hypothesis which attempted to link the effect of excess
ammonia in the brain with the effectiveness of the TCA cycle. The
common link is a-ketoglutarate,
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Fig. 2-Metabolic interrelationship between ammonia metabolism and TCA
cycle in the brain. The dotted (. . . . . ) line illustrates metabolic derangements
of the TCA cycle postulated to occur as a result of excess ammonia. (Adapted
with permission from Gastroenterology 49: 699, 1965.)

the succeeding members of the
cycle. It is apparent that this will
interfere with oxygen utilization
and reconstitution (or formation)
of adenosine triphosphate (ATP),
an overall process known as oxidative phosphorylation. The formation of ATP will be diminished in
direct proportion to the depletion
of a-ketoglutarate.
The second line of defense in
the process of ammonia detoxication in the brain is offered by the
reaction in which glutamic acid
reacts with ammonia to form glutamine (Fig. 2). This reaction requires ATP for energy and is catalyzed by glutamine synthetase. As
a result of the accentuated formation of glutamine, this compound
is elevated in the cerebrospinal
fluid and blood in patients with
hepatic coma.
Worcel and Erecinska (1962)
have also shown that the addition
of ammonia to rat liver mitochondria inhibited oxygen uptake when
a-ketoglutarate and pyruvic acid
were used as substrates. They postulated that the inhibitory action
of ammonia on the respiration of
rat liver mitochondria is due to
competition for DPNH between
glutamic dehydrogenase and electron chain transport (Fig. 2).
If these theoretical considerations are correct, when an increased amount of ammonia crosses
the blood-brain barrier and reacts
with a-ketoglutarate and glutamic
acid, brain ATP levels should be
decreased as a result of the combination of inadequate formation
and excessive utilization. For the
same reasons, a-ketoglutarate would
be expected to be low. Schenker
et al. ( 1967; Shorey, McCandless,
and Schenker, 1967) measured
ATP and a-ketoglutarate in the
brain of rats who were given toxic
doses of ammonium acetate .. ATP
and a-ketoglutarate were measured
in the rapidly frozen base and cortex of the brain. Their results indicate that the ATP levels were
unchanged in the cortex but definitely decreased at the base of the
35
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brain, with ammonia concentration
equal in both parts. These experiments offer for the first time in
vivo evidence of the toxic effect
of ammonia on energy metabolism
in the brain. At the same time, a
measurable decrease of phospho-creatine at the base was observed.
Glucose and glycogen decreased
significantly in both base and cortex.
The mechanism for this selective depletion of ATP at the base
of the brain is not known, but it
-could be due to the impaired formation of ATP, its increased utilization, or the combination of both.
The significance of selective ATP
and phosphocreatine depletion at
the base of the brain is not known.
However, the available evidence
suggests that one-third depletion of
ATP is deleterious in anoxic rats
( Dahl and Balfour, 1964). The
role of ATP in the maintenance
of proper cerebral function is also
not known, though it has been
postulated that energy provided by
ATP may be required for proper
transmission of nerve impulses
{Skou, 1965). The relationship between the state of consciousness
and ATP depletion was not clarified in these experiments.
The determination of a-ketoglutarate did not demonstrate any depletion of this intermediate either
in the cortex or at the base of the
brain. It is possible, however, that
the current methods cannot assess
small cerebral pools in highly differentiated compartments. These results, as well as the failure of ammonia to interfere in vitro with
e ither respiration or phosphorylation, are not compatible with Bessman's hypothesis.
McK.hann and Tower ( 1961)
showed that the addition of ammonium chloride to the brain
cortical slices caused significant reduction of oxygen uptake when
pyruvate or a-ketoglutarate were
used as a substrate. They concluded that ammonium interferes
with oxidative decarboxylation of
pyruvate and a-ketoglutarate. This
36

observation offers another possible
hypothesis applicable to the human
situation. Other factors such as deficient acetyl coenzyme A, metabolic inhibitors-either not detoxified in the liver or produced as a
result of ammonia intoxicationand medium chain fatty acids are
a few possible candidates which
have not yet been adequately studied.
Though a great step forward ,
these experiments have not yet offered a new concept relating to
the pathogenesis of hepatic encephalopathy.
The concentrated efforts to explain hepatic encephalopathy from
the standpoint of disor<lered ammonia metabolism heretofore have not
been rewarding. Geiger (1958),
however, in his experiment with
perfused cat brain, has opened new
avenues and new approaches. He
found that cat brain preparations
remained viable and were ahle to
perform normal neurolo~ical and
biochemical functions for a prolonged period of time with the liver
inserted into the circulation. This
was not the case when the brain
preparation was perfused with the
red cell suspension in the Ringer
solution devoid of organic substances normally present in blood.
This emphasizes the importance of
the metabolic interrelationship between the liver and the brain. The
implication of these experiments is
that normal brain function deoends
upon a normally functioning liver,
which may supply the brain with
some important metabolic precursors such as cytidin and uridin
which the brain is itself incapable
of producing (Webster, 1965). In
patients with cirrhosis, this metabolic interrelationship might be disturbed, resulting in abnormal brain
function.
A repeat of the Gei~er experiments with these thoughts in mind,
as well as new and systematic approaches in other areas, might offer
additional insight into the pathophysiology of this fascinating and
perplexing entity, which is so in-

adequately understood at the present time ..
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